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Lung functionThis cross-sectional study investigated the relationship between exposure to airborne indoor and outdoor partic-
ulate matter (PM) and cardiovascular and respiratory health in a population-based sample of 58 residences in
Copenhagen, Denmark. Over a 2-day period indoor particle number concentrations (PNC, 10–300 nm) and
PM2.5 (aerodynamic diameter b 2.5 μm) were monitored for each of the residences in the living room, and
outdoor PNC (10–280 nm), PM2.5 and PM10 (aerodynamic diameter b 10 μm)were monitored at an urban back-
ground station in Copenhagen. In the morning, after the 2-day monitoring period, we measured microvascular
function (MVF) and lung function and collected blood samples for biomarkers related to inﬂammation, in 78
middle-aged residents. Bacteria, endotoxin and fungi were analyzed in material from electrostatic dust fall
collectors placed in the residences for 4 weeks. Data were analyzed using linear regression with the generalized es-
timating equation approach. Statistically signiﬁcant associationswere found between indoor PNC, dominated by in-
door use of candles, and lower lung function, the prediabetic marker HbA1c and systemic inﬂammatory markers
observed as changes in leukocyte differential count and expression of adhesion markers on monocytes, whereas
C-reactive protein was signiﬁcantly associated with indoor PM2.5. The presence of indoor endotoxin was associated
with lower lung function and expression of adhesion markers on monocytes. An inverse association between out-
door PNC and MVF was also statistically signiﬁcant. The study suggests that PNC in the outdoor environment may
be associated with decreased MVF, while PNC, mainly driven by candle burning, and bioaerosols in the indoor
environment may have a negative effect on lung function and markers of systemic inﬂammation and diabetes.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Long-term exposure to particulate air pollution from trafﬁc and
other combustion sources is associated with an increase in general
mortality and morbidity from respiratory and cardiovascular diseases,
especially among elderly and people with previous respiratory and car-
diovascular diseases (Hoek et al., 2013). Short-term exposure to elevat-
ed levels of outdoor air pollution, lasting hours to several days, has been
linked to increased mortality and hospital admissions due to heart and
lung diseases (Ruckerl et al., 2011).l Health, Department of Public
5A, DK-1014 Copenhagen K,
. This is an open access article underAmbient air particulate matter (PM) is usually assessed by mass con-
centration in terms of PM10 (aerodynamic diameter b 10 μm) or PM2.5,
(aerodynamic diameter b2.5 μm),whereas ultraﬁne particles (UFP, diam-
eter b0.1 μm), contributing only few percent to the total mass, are often
characterized by particle number concentration (PNC). The composition
of ambient air PMvarieswidely and depends on the emission source, par-
ticle size, geographic location, atmospheric chemical transformations, and
meteorology (Putaud et al., 2010). UFP, especially from combustion pro-
cesses, are thought to be more harmful than larger particles due to their
large reactive surface area, chemical composition, high alveolar deposi-
tion, poor clearance and the potential for translocation to the systemic cir-
culation (Franck et al., 2011). Nevertheless, epidemiological evidence
supporting the speciﬁc hazards of UFP is relatively scarce, possibly due
to problems in exposure assessment, including high spatial variation
(Ruckerl et al., 2011). The mechanisms involved in the health effects ofthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Characteristics of the study participants Values are numbers or mean ± SD. LDL,
low-density lipoprotein; HDL, high-density lipoprotein.
Characteristics of participants Men Women Total
Gender 45 33 78
Age (years) 56 ± 4 53 ± 5 55 ± 5
Height (cm) 180 ± 6 169 ± 5 175 ± 8
Weight (kg) 85 ± 10.5 68 ± 9 78 ± 13
Body mass index (kg/m2) 26 ± 3 24 ± 3 25 ± 3
Diastolic blood pressure (mm Hg) 82 ± 8 79 ± 7 81 ± 8
Systolic blood pressure (mm Hg) 127 ± 13 124 ± 14 126 ± 13
Hemoglobin (mmol/L) 10 ± 1.1 9.2 ± 1.2 9.7 ± 1.2
Total cholesterol (mmol/L) 4.0 ± 0.8 4.2 ± 0.9 4.0 ± 0.8
LDL cholesterol (mmol/L) 2.6 ± 0.9 2.3 ± 0.6 2.4 ± 0.8
HDL cholesterol (mmol/L) 0.9 ± 0.2 1.4 ± 0.3 1.1 ± 0.3
Triglycerides (mmol/L) 1.5 ± 1.1 0.9 ± 0.5 1.2 ± 0.9
Subjects taking vasoactive medication 10 3 13
Subjects taking statins 1 1 2
Subjects not taking any drugs 35 30 65
373D.G. Karottki et al. / Environment International 73 (2014) 372–381PM include pulmonary and systemic inﬂammation, oxidative stress, al-
tered cardiac autonomic function, altered balance between coagulation
and ﬁbrinolysis, endothelial andmicrovascular dysfunction, atherosclero-
sis progression and plaque instability, as studied in panel and cross-
sectional studies with short-term exposure assessed from monitoring
stations or after controlled exposure (Brook et al., 2010). However, results
have shown less consistency for prognostic markers for cardiovascular
risk, including blood markers reﬂecting inﬂammation such as C-reactive
protein (CRP) and circulating leukocyte counts, cell expression of adhe-
sion molecules and impaired endothelial function (Li et al., 2012; Pope
et al., 2011; Ruckerl et al., 2011).
Assessing adverse health effects of exposure to indoor air PM at
home is important because people spend 80–90% of their time indoor
and the indoor pollutant levels are often greater than the outdoor pol-
lutant levels (Klepeis et al., 2001;Wallace, 1996). Of special global con-
cern is the indoor use of solid fuel. More than 3 mill deaths were
attributed to this cause in 2010 (Lim et al., 2012). Particles from out-
doors can be transported into the indoor environment by ventilation
and inﬁltration (Chen and Zhao, 2011). Indoor concentrations of PM
that originates from outdoor sources are affected by multiple factors
such as location, weather conditions (including outdoor temperature
andwind speed), outdoor PMconcentrations, the chemical and physical
properties of the pollutants (speciﬁcally deposition and resuspension
rate, and chemical reactions), building characteristics, air exchange
rates, window openings and personal behaviors (Morawska et al.,
2013). In addition, a variety of indoor emission sources such as candle
burning, cooking, heating devices, environmental tobacco smoke, ofﬁce
equipment, biological sources, and human activity contribute substan-
tially to the total personal exposure (Morawska et al., 2013; Wallace
and Ott, 2011). Indoor air PM also include bioaerosols such as bacteria,
fungi, endotoxin and other components found in settled dust which
can have inﬂammatory potential and effect on e.g. respiratory health
(Tischer et al., 2011). In addition, indoor suspended PM including soot
particles may act as potential allergen carriers (Ormstad, 2000). Inhala-
tion of indoor air pollutants together with these indoor aeroallergens or
endotoxin may induce airway inﬂammation, leading to the exacerba-
tion of airway and allergic diseases, including asthma (Leung et al.,
2002). Studies on adults with asthma and rhinitis have shown that the
indoor home environment was associated with lung dysfunction, poor
health status, and disease severity (Blanc et al., 2005). Nevertheless,
there is a lack of studies relating indoor concentrations of UFPs to respi-
ratory and cardiovascular health outcomes, especially with parallel as-
sessment of associations with outdoor pollutants.
We conducted a cross-sectional study to investigate whether micro-
vascular function (MVF) and lung function were inversely associated
with exposure to real-life levels of air pollution in the indoor and out-
door environments in an urban population. MVF and endothelial func-
tion have been widely used for cardiovascular hazard identiﬁcation of
PM (Moller et al., 2011). The outdoor air pollution levels were assessed
by urban backgroundmonitoring in terms of PM10, PM2.5, mean particle
diameter and PNC (size range 10–280 nm), which is highly dominated
by UFP. The indoor exposure assessment included measurements of
PNC (size range 10–300 nm) also highly dominated by UFP from candle
burning, which is an important source in the winter period in Denmark
(Bekö et al., 2013), mean particle diameter, PM2.5, and presence of
bioaerosol components in settled dust. To explore possiblemechanisms,
we investigated inﬂammation markers in terms of CRP and leukocyte
counts, aswell as expression levels of surface adhesionmolecules on cir-
culating monocytes by ﬂow cytometry, because monocyte activation
with attachment to the endothelium is an important event in the ath-
erosclerotic process (Libby et al., 2002).
2. Materials and methods
The study protocol was approved by The Committees on Health Re-
search Ethics in the Capital Region of Denmark (ﬁle no H-4-2010-102),in accordance with the Declaration of Helsinki. All participants gave
written informed consent prior to enrolment in the study.
2.1. Study subjects
We recruited participants from the Copenhagen Aging and Midlife
Biobank (CAMB) (Avlund et al., 2014). A total of 80 (22 couples
and 36 singles) non-smoking volunteers participated in the study.
They had been living in Copenhagen for more than 6 months, in
residences within distances of not more than 500 m from major roads
(N10,000 vehicles per day). Two participants with very high CRP levels
were excluded from the data analysis due to recent infections treated
with antibiotics.
The characteristics of the 78 participants are presented in Table 1.
The mean age was 55 years with a range from 41 to 68 years, and the
average body mass index (BMI) was 25 kg/m2 with a range from 17 to
37 kg/m2. Thirteen participants were taking vasoactive medications
(angiotensin-converting enzyme (ACE) inhibitors, angiotensin II recep-
tor blockers, calcium channel blockers, or β-adrenoreceptor blockers),
and 2 participants were also taking statins.
2.2. Study procedure
The study had a cross-sectional designwith exposuremonitoring for
a 2-day period (on average 45 h) prior to the assessment of health
outcomes. The participants were asked to ﬁll out a questionnaire
about their health, lifestyle and time–activity, including use of candles
and cooking, and with detailed inquiry about their housing and indoor
climate. Measurements of MVF and lung function, and the collection
of blood samples were carried out at the end of the 2-day indoor air
monitoring period. The study lasted from late October 2011 to mid-
February 2012.
2.3. Exposure assessment
Data from the measurements of indoor PNC has been reported
earlier (Bekö et al., 2013). In brief, indoor PNC was monitored for
about 48 hwith Philips NanoTracer1000 (Philips Aerasense, Eindhoven,
Netherlands) particle counters, which operated continuously with a
time resolution of 16 s. The instrument detected the number concentra-
tion and mean diameter in the size range of particles between 10 and
300 nm in mobility diameter. We have shown a reasonable agreement
between the NanoTracer and a stationary Scanning Mobility Particle
Sizer (Bekö et al., 2013). In each residence one instrument was placed
at a height between 0.5 and 1.5 m above ﬂoor level in the living room
(Bekö et al., 2013). The average PNC over the whole measured period
in each residence was used in the analyses. Source events with sudden
374 D.G. Karottki et al. / Environment International 73 (2014) 372–381sharp peaks in indoor PNC during the 48-h monitoring were attributed
to burning of candles, cooking or unknown sources as described previ-
ously (Bekö et al., 2013). Exposure related to source events involving
candles or cooking were calculated as the average PNC minus back-
ground levels of PNC and timed the duration of the elevated concentra-
tion above background level.
The indoormass concentrations of PM2.5weremeasured gravimetri-
cally on Fluoropore Membrane PTFE ﬁlters (37 mm; pore size, 1.0 μm;
Millipore, Billerica, MA, USA). The setup consisted of a cyclone sampling
head GK 2.05-KTL (BGI Inc., Waltham, MA, USA) with a cutoff diameter
of 2.5 μm, a ﬁlter and a sampling pump. The airﬂow through the sam-
pling ﬁlter was adjusted to 4 L/min at the start of each measurement
session and it was checked again at the end of themeasurement period.
Before and after sampling the ﬁlters were kept at constant temperature
(22 °C) and relative humidity (50%) for 24 h before beingweighed. The
average airﬂow was used to calculate the average PM2.5 concentration
in each residence during the measurement period.
Indoor settled dustwas collected by an Electrostatic Dust Fall Collec-
tor (EDC) with two electrostatic cloths (19 × 11 cm) (ZEEMAN Alphen,
Netherlands) placed on an open surface at ≥1 m above the ﬂoor level
and analyzed for bacteria, endotoxin and fungi expressed per surface
area of the EDCasdescribed elsewhere (Madsen et al., 2012). The collec-
tion of indoor settled dust had to be continued for 28 days after the start
of the particle measurements to allow for variation in exposure through
time; the results obtained by this method correlates well with results
obtained by a standardmethod for 6-h collection of airbornebioaerosols
(Frankel et al., 2012).
Ambient air pollution data were measured by Aarhus University as
part of the Danish Air Quality Monitoring Programme (Ellermann
et al., 2012) at the Copenhagen urban background monitoring station
at the roof of a 20 m high building (H.C. Ørsted Institute) in accordance
withWHO recommendations as described elsewhere (Wichmann et al.,
2013). Themeasurements,whichwere performedprior to themeasure-
ment of health outcomes, included 48-hour averages of PNC in the size
range between 10 and 280 nm in mobility diameter (custom-built
Differential Mobility Particle Sizer), PM10 and PM2.5 mass concentra-
tions (SM200 instruments, OPSIS AB; Furulund, Sweden). All homes
were within a distance of 8 km from the monitoring station with an av-
erage distance of 4 km. They were mainly located upwind to the station
at the prevailing westerly wind directions in the study period, although
19 participants were studied during stagnant air conditions.
2.4. Measurement of microvascular- and lung function
MVFwasmeasured non-invasively via peripheral arterial tonometry
(PAT) using the portable EndoPAT 2000 (Itamar Medical Ltd., Cesaria,
Israel), as previously described in detail (Patvardhan et al., 2010). The
method uses a pair of ﬁnger-mountable pneumatic sensors of each
hand that records vascular function changes in the digital pulse wave-
form (PAT signal). Vascular function changes in the PAT signal are elic-
ited by creating a downstream hyperemic response. A blood pressure
cuff was placed above the elbow on one arm, while the contra-lateral
arm served as a control arm. Resting blood pressure was taken before
each MVF measurement. The EndoPAT protocol consisted of three
recording stages: 5 minute baseline PAT signal measurement, 5 minute
occlusion of ﬂow through the brachial artery on the test arm (supra sys-
tolic cuff inﬂation) and 5 minute post-occlusion reactive hyperemia
(RH). The response to reactive hyperemia was calculated automatically
through a computer algorithm and a RH-PAT index (RHI) was created
by the ratio of the post- and pre-occlusion values of the PAT signal.
RHI values were normalized to measurements from the control arm.
The lung function was measured by spirometry in accordance with
the American Thoracic Society/European Respiratory Society standard
guidelines (Miller et al., 2005) using the EasyOne Plus spirometer (ndd
Medical Technologies; Zurich Switzerland) as previously described
(Karottki et al., 2013). The spirometric measures of forced expiratoryvolume in the ﬁrst second (FEV1) and forced vital capacity (FVC) were
collected after MVF measurements. The data were digitally stored and
the largest FVC and FEV1 from at least three acceptable trials were
used; the ratio of FEV1 to FVC was calculated.2.5. Measurement of biomarkers
On the day of the home visits, peripheral venous blood samples were
collected in CPT™ tubes with sodium heparin (BD Vacutainer® CPT™,
Becton Dickinson A/S, Brøndby, Denmark) for peripheral blood mononu-
clear cell (PBMC) isolation and in EDTA tubes for hematological analyses.
Measurements of hemoglobin, and leukocyte counts and their differential
proﬁle (lymphocytes, monocytes, neutrophils and eosinophils) were per-
formed by two automatic hematological analyzers, Chempaq (Chempaq
XBC, Denmark) and HemoCue (HemoCue AB, Sweden), respectively.
The concentration of glycosylated hemoglobin (HbA1c) was determined
using the Bio-Rad in2it A1c test cartridges (Bio-Rad, USA).
We separated PBMC for storage at −80 °C in freezing media
consisting of 50% fetal bovine serum (FBS, GibcoRBL), 40% culturemedi-
um (RPMI 1640, GibcoRBL) and 10% dimetyl sulfoxide for ﬂow cytome-
try analyses.
Plasma CRP, total cholesterol, high-density lipoprotein (HDL), low-
density lipoprotein (LDL) and triglycerides were analyzed at the Depart-
ment of Clinical Biochemistry, Copenhagen University Hospital.
Direct immunoﬂuorescence of PBMCs was performed on a BD
Accuri™ C6 ﬂow cytometer with BD Accuri CFlow® Plus software (BD
Bioscience, Brøndby, Denmark) as previously described (Karottki et al.,
2013). Brieﬂy, speciﬁc surface staining of the activation status of mono-
cytes was performed with ﬂuorescein isothiocyanate (FITC)-conjugated
anti-CD49d (ITGA4), +Allophycocyanin (APC)-conjugated anti-CD11b
(Mac1α) and FITC-conjugated anti-CD31 (PECAM-1) + Phycoerythrin
(PE)-conjugated anti-CD62L (L-selectin) mouse monoclonal antibodies
(BD Bioscience, Brøndby, Denmark). PBMCs were placed in round-
bottom 96-well plates (approximately 105 cells per well), stained for
30 min at 4 °C, washed twice with stain buffer with centrifugation at
250 g for 5min, resuspended in 100 μL stain buffer and analyzed immedi-
ately. Monocytes were selectively gated based on their characteristic for-
ward scatter and side scatter properties. The expression of CD11b, CD31,
CD62L and CD49d onmonocyteswas quantiﬁed as percentage of positive
cells from each sample.2.6. Statistical analysis
Associations between the indoor and outdoor pollutant levels were
assessed by Pearson correlation coefﬁcients. Linear regression models
with the Generalized Estimating Equation approach (GEE) were used
to estimate the association between log-transformed health outcomes
and indoor and outdoor exposure variables, accounting for correlation
between individuals living at the same address. Separate models were
ﬁtted for each outcome, adjusted for age, gender, BMI and in sensitivity
analyses for intake of vasoactive drugs or statins or use of candles as cat-
egorical variable. Additionally, the associations between the exposure
and MVF were assessed for a subgroup of study participants who did
not take any drugs (n= 65), adjusted for age, gender, and BMI. Further-
more, we included adjustment for the time the home was unoccupied
(on average 20% of the total time) as an estimate of time spent outside
in sensitivity analyses of the signiﬁcant associations found.
Results were expressed as percentage change with 95% conﬁdence
intervals of an outcome per increase in a pollutant's interquartile
range (IQR) concentration. We used the IQRs in the analysis of the in-
door and the outdoor data pollutant to allow direct comparison of effect
estimates. A value of p ≤ 0.05 was considered statistically signiﬁcant.
Analyses were performed using STATA software (version 12, StataCorp
LP, College Station, Texas, USA).
Table 2
Medians (5th, 95th percentiles) of the indoor and outdoor air pollutants and Pearson correlation coefﬁcients (p-value) between the variables.
Exposure characteristics Indoor Outdoor
PNC
(103/cm3)
n = 56
Mean particle
diameter
(nm)
n = 56
PM2.5
(μg/m3)
n = 50
Candle total daily
exposure
(103/cm3 × h/day)
n = 56
Cooking total daily
exposure
(103/cm3 × h/day)
N = 56
Endotoxin
(EU/m2)
N = 58
Fungi
(CFU/m2)
N = 58
Bacteria
(CFU/m2)
N = 58
PNC
(103/cm3)
N = 36
Mean particle
diameter
(nm)
N = 36
PM2.5
(μg/m3)
N = 58
PM10
(μg/m3)
N = 58
Median
(5th; 95th percentile)
12.4
(2.8; 104)
75.9
(52.6; 102)
11.8
(3.4; 34.2)
2.6
(0; 2217)
20.0
(0; 427)
1354
(236; 6105)
64,114
(6698; 284,210)
25,837
(1435; 325,359)
3.9
(3.1; 5.2)
65.7
(49.2; 84.7)
14.4
(6.4; 40.5)
21.4
(10.5; 46.4)
Indoor PNC (103/cm3) 1.0000
Mean particle diameter
(nm)
−0.23
(0.08)
1.0000
PM2.5
(μg/m3)
0.33⁎
(0.02)
0.29⁎
(0.04)
1.0000
Candle total daily exposure
(103/cm3 × h/day)
0.97⁎
(0.00)
−0.23
(0.08)
0.24
(0.10)
1.0000
Cooking total daily exposure
(103/cm3 × h/day)
0.10
(0.44)
0.13
(0.35)
0.27
(0.06)
−0.12
(0.39)
1.0000
Endotoxin
(EU/m2)
−0.15
(0.28)
−0.005
(0.97)
−0.12
(0.39)
−0.14
(0.28)
0.01
(0.93)
1.0000
Fungi
(CFU/m2)
0.08
(0.55)
−0.06
(0.66)
0.06
(0.68)
0.08
(0.53)
0.05
(0.71)
0.25
(0.06)
1.0000
Bacteria
(CFU/m2)
0.01
(0.91)
−0.01
(0.94)
−0.04
(0.77)
0.01
(0.92)
−0.03
(0.80)
0.09
(0.48)
0.16
(0.22)
1.0000
Outdoor PNC
(103/cm3)
−0.05
(0.76)
0.06
(0.72)
0.04
(0.82)
−0.08
(0.65)
0.03
(0.88)
0.04
(0.80)
0.14
(0.41)
−0.13
(0.44)
1.0000
Mean particle diameter
(nm)
−0.31
(0.07)
0.48⁎
(0.00)
−0.12
(0.50)
−0.31
(0.06)
0.13
(0.44)
−0.19
(0.24)
−0.23
(0.18)
−0.31
(0.06)
0.09
(0.60)
1.0000
PM2.5
(μg/m3)
−0.11
(0.40)
0.62⁎
(0.00)
0.001
(0.99)
−0.15
(0.25)
0.23
(0.09)
−0.10
(0.45)
−0.11
(0.39)
−0.03
(0.84)
0.32
(0.05)
0.60⁎
(0.00)
1.0000
PM10
(μg/m3)
−0.12
(0.39)
0.56⁎
(0.00)
0.002
(0.99)
−0.17
(0.22)
0.25
(0.06)
−0.10
(0.47)
−0.15
(0.25)
−0.04
(0.74)
0.39⁎
(0.02)
0.57⁎
(0.00)
0.97⁎
(0.00)
1.0000
PNC, particle number concentration; PM2.5 and PM10, mass of particulate matter with aerodynamic diameter less than 2.5 μm and 10 μm; EU, endotoxin units; CFU, colony forming units.
⁎ p b 0.05.
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3.1. Exposure characterization
Table 2 outlines the results from the 2-day indoor air monitoring of
the 58 residences for PNC, mean particle diameter PM2.5 and the level of
endotoxin, fungi and bacteria levels in dust collected for 4 weeks. The
levels of the indoor PNC have recently been reported (Bekö et al.,
2013). The ambient air PNC, mean particle diameter, PM2.5 and PM10
concentrations, monitored at an urban background station in the same
2-day period preceding the measurements of health outcomes are also
summarized in Table 2. There was a signiﬁcant positive correlation be-
tween indoor PNC and PM2.5, whereas therewere inverse positive corre-
lations between indoor PNC andoutdoor PM2.5 and PM10 levels, although
thesewere not signiﬁcant. The average indoor PNC levels over thewhole
monitoring periodwere strongly associatedwith the estimated exposure
related to candle burning as source events. Thus, exposure related to can-
dle burning and total average PNC showed a correlation coefﬁcient of
0.97 (p = 0.00) across all homes despite the fact that candles were
only burned in 28 of the homes. In contrast the average indoor PNC
levels were weakly correlated with estimated exposure related to
cooking (r= 0.10; p= 0.44). The indoormeanparticle diameter corre-
lated with the indoor mass concentration of PM2.5 and with mean out-
door particle diameter and mass concentration of PM2.5 and PM10. The
mean outdoor particle diameter correlatedwith themass concentration
of outdoor PM2.5 and PM10. Outdoor levels of PNC and PM2.5 were signif-
icantly correlated with PM10 (Table 2).3.2. Biomarkers and physiological functions
The health outcome variables are summarized in Table 3, in total and
by gender. The associations between the health outcomes and the
indoor and outdoor air pollutants estimated as percent change per IQR
increase by the GEE model are presented in Table 4.Table 3
Medians (5th, 95th percentiles) of the outcomes.
Biomarkers Total
MVF 1.77
(1.14, 2.87)
C-reactive protein
(mg/L)
0.6
(0.1, 3.4)
HbA1c
(mmol/mol)
36
(30, 42)
Leukocytes
(×109 cells/L)
5.4
(3.8, 7.7)
Lymphocytes
(×109 cells/L)
2.0
(1.2, 3.1)
Monocytes
(×109 cells/L)
0.6
(0.4, 0.8)
Neutrophils
(×109 cells/L)
2.8
(1.8, 4.3)
Eosinophils
(×109 cells/L)
0.2
(0, 0.3)
CD31 (%) 97.5
(92.6, 99.4)
CD62L (%) 65.8
(38.0, 81.5)
CD11b (%) 67.8
(32.9, 84.1)
CD49d (%) 76.2
(31.3, 99.1)
FEV1/FVC 0.77
(0.60, 0.86)
MVF, microvascular function; HbA1c, hemoglobin A1c (glycosylated hemoglobin).
CD, cluster of differentiation; FEV1, forced expiratory volume 1 s (L); FVC, forced vital capacityMVF was signiﬁcantly inversely associated with outdoor PNC (9%
decrease per IQR increase), but not with outdoor PM2.5 or PM10. The
association between outdoor PNC andMVF remained statistically signif-
icant with 8.3% decrease per IQR, when restricting the study population
to participantswhodid not use any drugs (n=65). Therewas no signif-
icant association between MVF and indoor PNC, indoor PM2.5 or settled
dust levels of bacteria, endotoxin, and fungi. In contrast, the prediabetic
marker HbA1c was signiﬁcantly associated with indoor PNC (2%
increase per IQR), but not with other exposure markers. CRP showed
signiﬁcant association with the indoor levels of PM2.5 (24% increase
per IQR). There were consistent but not signiﬁcant positive associations
between CRP and outdoor PNC, PM2.5 and PM10 levels. Counts of leuko-
cytes, monocytes and lymphocytes were signiﬁcantly positively associ-
ated with indoor exposure to PNC (3.5–6.6% increase per IQR), whereas
the CD11b expression on monocytes showed an inverse association
with a 4% decrease per IQR increase in PNC (Table 4). In addition, eosin-
ophil counts were inversely associated with levels of indoor PM2.5 and
bacteria in settled dust, CD62L and CD11b expression was signiﬁcantly
inversely associated with levels of endotoxin in settled dust, whereas
CD62L only was inversely associatedwith fungi levels. High levels of in-
door PNC and endotoxin were associated with signiﬁcantly lower lung
function with 2% reduction in the FEV1/FVC ratio per IQR increase of
both, whereas none of the other exposure markers showed signiﬁcant
associations (Table 4). The adjustment of the associations between out-
comes and outdoor pollutants for the outdoor temperature did not
change the main results (data not shown). Similarly, adjustment for
time the home was unoccupied during the monitoring period did not
change the magnitude of any of the found signiﬁcant association, al-
though the associations between CRP and eosinophil counts and indoor
PM2.5 lost statistical signiﬁcance (data not shown). The adjustment for
use of candles (data not shown) and intake of drugs as categorical var-
iable had no effect on the statistical signiﬁcance of any of the associa-
tions (Table 5). Analyses of the estimated source speciﬁc exposures
showed candle burning related exposure to be signiﬁcantly associated
with a lower lung function, and with higher HbA1c and leukocyteMen Women
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(1.39, 2.43)
1.77
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2.6
(1.6, 4.3)
2.9
(1.9, 4.6)
0.2
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0.1
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(94.1, 99.4)
97.1
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0.78
(0.61, 0.85)
0.77
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(L).
Table 4
Percent changes (95% conﬁdence interval) in outcome levels associated with one interquartile range (IQR) increase in indoor and outdoor exposures among 78 participants, estimated by GEE models on the natural logarithm of the outcomes, and
subjects nested in residence; all models were adjusted for age, gender, BMI.
Outcome variables Indoor exposure characteristics
(IQR)
Outdoor exposure characteristics
(IQR)
PNC
(32,109 cm−3)
PM2.5
(12.1 μg/m3)
Bacteria
(69,856 CFU)
Endotoxin
(2111 EU)
Fungi
(76,555 CFU)
PNC
(1001 cm−3)
PM2.5
(7.3 μg/m3)
PM10
(11.3 μg/m3)
N = 75 N = 68 N = 78 N = 78 N = 78 N = 49 N = 78 N = 78
MVF 2.3 (−2.0, 6.9) −2.8 (−10.1, 5.0) −0.5 (−3.3, 2.4) −0.2 (−5.2, 5.1) 0.1 (−3.3, 3.6) −8.9⁎ (−15.9,−1.4) 0.1 (−3.9, 4.5) −0.9 (−6.8, 5.4)
MVF in 65 participants not taking
vasoactive drugs
2.5 (−2.0, 7.2) −1.4 (−12.1, 10.7) −0.8 (−3.7, 2.2) −2.9 (−8.2, 2.6) 0.4 (−4.1, 5.1) −8.3⁎ (−15.3,−0.7) 0.3 (−5.0, 6.1) −0.2 (−8.3, 8.7)
HbA1c 2.1⁎ (0.9, 3.3) 2.2 (−3.1, 7.8) 0.5 (−1.2, 2.4) 0.03 (−2.3, 2.4) −0.4 (−1.9, 1.1) −1.5 (−8.1, 5.5) −1.9 (−7.3, 3.7) 0.5 (−5.0, 6.4)
C-reactive protein −5.8 (−15.9, 5.5) 23.7⁎ (0.4, 52.4) −2.7 (−11.1, 6.6) −13.6 (−30.1, 6.9) −1.7 (−14.6, 13.2) 46.5 (−10.5, 139.9) 14.4 (−3.5, 35.7) 22.0 (−4.7, 56.2)
Leukocytes 3.5⁎ (0.2, 6.9) 2.6 (−4.1, 9.7) −0.2 (−2.1, 1.7) 3.7 (−2.3, 10.1) −0.4 (−4.3, 3.6) −3.4 (−12.4, 6.5) −2.3 (−5.5, 1.0) −3.3 (−7.7, 1.3)
Lymphocytes 6.6⁎ (2.0, 11.5) 1.1 (−7.4, 10.5) −0.6 (−4.2, 3.0) 2.7 (−4.4, 10.4) 0.5 (−5.9, 7.2) −0.5 (−14.6, 15.9) 0.3 (−3.5, 4.3) −1.8 (−7.5, 4.3)
Monocytes 4.1⁎ (0.4, 7.9) 0.4 (−7.1, 8.5) 0.5 (−2.0, 3.0) 1.9 (−3.8, 7.9) −0.7 (−5.3, 4.1) −4.1 (−14.9, 8.1) −0.1 (−3.6, 3.5) −0.7 (−5.7, 4.5)
Neutrophils 1.0 (−2.7, 4.9) 1.2 (−5.5, 8.4) −0.3 (−5.0, 4.6) 2.2 (−5.6, 10.6) −2.1 (−6.4, 2.5) 1.7 (−15.5, 22.3) −3.4 (−6.9, 0.2) −4.9 (−10.0, 0.4)
Eosinophils 7.6 (−0.2, 16.0) −15.3⁎ (−27.8,−0.8) −6.9⁎ (−12.5,−0.9) 2.6 (−8.9, 15.6) 3.3 (−7.6, 15.5) 13.4 (−11.2, 44.9) 6.6 (−11.4, 28.2) 4.6 (−17.7, 32.9)
CD31 −0.3 (−0.8, 0.3) −2.0 (−4.9, 0.9) −0.2 (−0.8, 0.3) −1.3 (−2.7, 0.1) −0.7 (−2.1, 0.7) −1.1 (−2.7, 0.5) −0.3 (−0.7, 0.1) −0.6 (−1.2, 0.1)
CD62L 3.6 (−0.2, 7.6) 0.8 (−6.8, 9.2) −1.9 (−5.6, 1.9) −8.4⁎ (−15.4,−0.7) −5.7⁎ (−10.6,−0.5) 4.3 (−8.3, 18.8) −0.2 (−4.1, 3.9) −1.4 (−6.9, 4.4)
CD11b −4.4⁎ (−8.3,−0.3) −4.0 (−14.6, 7.8) −1.6 (−5.9, 2.8) −8.2⁎ (−14.2,−1.7) −5.1 (−12.1, 2.6) −8.7 (−19.5, 3.5) −3.7 (−8.9, 1.7) −5.5 (−12.6, 2.2)
CD49d 2.1 (−4.3, 9.1) 3.6 (−5.1, 13.1) 2.6 (−0.9, 6.2) 0.8 (−7.9, 10.3) 2.2 (−4.3, 9.3) −5.2 (−17.1, 8.3) 2.3 (−6.3, 11.8) 0.9 (−11.8, 15.4)
FEV1/FVC −2.1⁎ (−3.8,−0.4) −2.2 (−6.1, 1.8) 0.1 (−0.8, 1.0) −2.2⁎ (−3.8,−0.7) −0.2 (−2.2, 1.8) 2.2 (−0.8, 5.3) 0.5 (−0.6, 1.7) 1.1 (−0.8, 3.2)
MVF, microvascular function; HbA1c, hemoglobin A1c (glycosylated hemoglobin); CD, cluster of differentiation; FEV1, forced expiratory volume 1 s (L); FVC, forced vital capacity (L); EU, endotoxin units; CFU, colony forming units.
⁎ p b 0.05.
Table 5
Percent changes (95% conﬁdence interval) in outcome levels associated with one interquartile range (IQR) increase in indoor and outdoor exposures among 78 participants, estimated by GEE models on the natural logarithm of the outcomes, and
subjects nested in residence; all models were adjusted for age, gender, BMI and intake of vasoactive drugs. See Table 4 for exact N and IQR for each exposure characteristic.
Outcome variables Indoor exposure characteristics Outdoor exposure characteristics
PNC
(32,109 cm−3)
PM2.5
(12.1 μg/m3)
Bacteria
(69,856 CFU)
Endotoxin
(2111 EU)
Fungi
(76,555 CFU)
PNC
(1001 cm−3)
PM2.5
(7.3 μg/m3)
PM10
(11.3 μg/m3)
MVF 2.3 (−2.0, 6.8) −2.2 (−9.5, 5.7) −0.8 (−3.8, 2.3) −0.4 (−5.7, 5.1) 0.1 (−3.2, 3.6) −8.4⁎ (−15.2,−1.0) −0.1 (−4.2, 4.2) −1.0 (−6.9, 5.2)
HbA1c 2.1⁎ (0.9, 3.3) 2.2 (−3.2, 7.9) 0.5 (−1.2, 2.3) 0.02 (−2.1, 2.2) −0.4 (−1.9, 1.1) −1.6 (−7.5, 4.8) −1.9 (−7.3, 3.7) 0.5 (−4.7, 6.1)
C-reactive protein −5.7 (−15.5, 5.3) 24.9⁎ (1.3, 54.1) −2.4 (−10.8, 6.9) −13.4 (−30.3, 7.6) −1.6 (−14.6, 13.2) 46.3 (−10.5, 139.4) 14.9 (−2.9, 36.2) 22.4 (−3.9, 55.8)
Leukocytes 3.5⁎ (0.2, 6.9) 2.0 (−4.4, 9.4) −0.03 (−1.8, 1.8) 3.9 (−2.1, 10.3) −0.4 (−4.1, 3.4) −3.7 (−12.7, 6.2) −2.1 (−5.3, 1.1) −3.2 (−7.6, 1.5)
Lymphocytes 6.7⁎ (2.3, 11.4) −0.01 (−8.6, 9.4) −0.3 (−3.8, 3.3) 3.1 (−3.9, 10.6) 0.4 (−5.5, 6.8) −1.0 (−15.5, 15.9) 0.6 (−3.6, 4.9) −1.6 (−7.7, 4.8)
Monocytes 4.2⁎ (0.6, 7.8) −0.7 (−8.5, 7.8) 0.9 (−1.5, 3.4) 2.4 (−3.2, 8.3) −0.8 (−5.0, 3.6) −6.3 (−17.6, 6.7) 0.4 (−3.2, 4.3) −0.3 (−5.5, 5.2)
Neutrophils 1.0 (−2.7, 5.0) 0.7 (−7.0, 9.2) −0.3 (−5.0, 4.6) 2.2 (−5.6, 10.7) −2.1 (−6.4, 2.4) 0.8 (−15.5, 20.2) −3.4 (−6.8, 0.1) −4.9 (−10.0, 0.5)
Eosinophils 7.6 (−0.2, 15.9) −16.1⁎ (−29.2,−0.7) −6.9⁎ (−12.4,−0.9) 2.8 (−8.6, 15.8) 3.3 (−7.7, 15.5) 13.4 (−11.0, 44.6) 6.8 (−11.2, 28.5) 4.8 (−17.5, 33.3)
CD31 −0.3 (−0.8, 0.3) −2.3 (−5.1, 0.7) −0.2 (−0.7, 0.3) −1.3 (−2.7, 0.1) −0.7 (−2.1, 0.7) −1.1 (−2.8, 0.6) −0.3 (−0.7, 0.1) −0.5 (−1.2, 0.1)
CD62L 3.3 (−0.6, 7.3) 1.4 (−6.5, 10.1) −2.2 (−5.9, 1.7) −8.3⁎ (−15.7,−0.2) −5.7⁎ (−10.9,−0.2) −0.9 (−4.6, 3.0) −2.0 (−7.3, 3.5)
CD11b −4.4⁎ (−8.2,−0.4) −4.7 (−14.8, 6.7) −1.5 (−5.7, 2.9) −8.1⁎ (−14.0,−1.7) −5.0 (−11.9, 2.5) −9.3 (−20.2, 3.0) −3.6 (−8.7, 1.8) −5.4 (−12.5, 2.2)
CD49d 2.1 (−4.2, 8.8) 4.6 (−4.7, 14.9) 2.0 (−1.6, 5.7) 0.1 (−8.0, 8.9) 2.2 (−4.9, 10.0) −4.9 (−16.6, 8.6) 1.6 (−6.7, 10.7) 0.3 (−11.4, 13.6)
FEV1/FVC −2.1⁎ (−3.7,−0.2) −2.7 (−6.1, 0.9) 0.3 (−0.6, 1.2) −2.1⁎ (−3.6,−0.5) −0.2 (−1.9, 1.4) 2.3 (−0.5, 5.3) 0.7 (−0.2, 1.7) 1.4 (−0.3, 3.2)
MVF, microvascular function; HbA1c, hemoglobin A1c (glycosylated hemoglobin); CD, cluster of differentiation; FEV1, forced expiratory volume 1 s (L); FVC, forced vital capacity (L); EU, endotoxin units; CFU, colony forming units. Blank boxmeans
that the model could not be run.
⁎ p b 0.05.
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Table 6
Percent changes (95% conﬁdence interval) in outcome levels associated with use of candles in the home in general or one interquartile range (IQR) increase in source-related indoor ex-
posures among 75 participants, estimated by GEE models on the natural logarithm of the outcomes, and subjects nested in residence; all models were adjusted for age, gender and BMI.
Outcome variables Source-related indoor exposure characteristics (IQR)
Use of candles in home
yes/no
Candle burning related exposure
(557,000 cm−3 × h/day)
Cooking related exposure
(143,000 cm−3 × h/day)
HbA1c 2.5 (−2.6, 7.9) 1.6⁎ (0.7, 2.5) −0.5 (−2.9, 2.1)
Leukocytes 4.9 (−4.8, 15.6) 2.9⁎ (0.8, 5.1) −1.1 (−2.9, 0.7)
Lymphocytes 20.4⁎ (4.3, 39.0) 6.2⁎ (2.9, 9.7) −4.0 (−8.7, 1.0)
Monocytes 8.8 (−2.7, 21.7) 3.3⁎ (0.8, 5.9) −0.1 (−2.8, 2.7)
CD11b −2.2 (−16.0, 13.8) −2.6 (−6.2, 1.1) −2.2 (−7.7, 3.6)
FEV1/FVC −0.09 (−4.2, 4.2) −1.6⁎ (−3.0,−0.1) 0.03 (−1.6, 1.7)
HbA1c, hemoglobin A1c (glycosylated hemoglobin); CD, cluster of differentiation; FEV1, forced expiratory volume 1 s (L); FVC, forced vital capacity (L).
⁎ p b 0.05.
378 D.G. Karottki et al. / Environment International 73 (2014) 372–381counts (Table 6). In contrast, use of candles in the home as a categorical
variable was only associated with lymphocyte counts whereas the
exposure related to cooking showed no association with any outcome
(Table 6).
4. Discussion
We used a population-based study on air quality in Danish resi-
dences to evaluate the relationship between indoor and outdoor parti-
cle concentrations and indoor bioaerosols, and health outcomes in
terms of MVF, lung function, systemic biomarkers of inﬂammation,
monocyte activation and the prediabetic marker HbA1c. MVF was in-
versely associated with outdoor PNC, whereas the indoor PNC level,
mainly driven by candle burning, was associated with lower lung func-
tion, and with higher HbA1c and leukocyte counts. The expression of
CD11b on monocytes was positively associated only with indoor PNC
levels. The indoor PM2.5 levels were positively associated with CRP
and inversely associated with the number of eosinophils. The indoor
bioaerosol levels in settled dust were all inversely associated with
some of the outcomes: levels of endotoxin with lung function and
monocyte activation, and bacteria and fungi levels with the number of
eosinophils and CD62L expression on monocytes in the blood,
respectively.
We did not have sufﬁcient statistical power to assesswhether intake
of vasoactive drugs modiﬁed the association between the exposure to
outdoor PNC and MVF, but the association was also signiﬁcant among
subjects not taking vasoactive drugs (8.3% decrease per IOR). Recent
results from an intervention study with air ﬁltration in the homes of
elderly residents showed that the achieved PM2.5 decrease in the bed-
room was signiﬁcantly associated with improved MVF within 2 days
mainly in subjects not taking any vasoactive or other drugs suggesting
that the drugs might mask such short-term effects (Karottki et al.,
2013). The association between the 2-day mean of outdoor PNC levels
and lower MVF is consistent with the notion that short-term exposure
to diesel combustion-related particleswith exercise promoted endothe-
lial dysfunction (Langrish et al., 2012;Miller et al., 2012).Moreover, two
short-term intervention studies with ﬁltration of indoor air resulting in
60–70% decrease in indoor PNC and/or PM2.5 for 2–7 days, in areas with
either trafﬁc or wood smoke pollution, showed increased MVF in the
subjects, including elderly people (Allen et al., 2011; Brauner et al.,
2008a). However, a third air ﬁltration study among young healthy sub-
jects showed no effect on MVF (Weichenthal et al., 2013). No effect of
24-hour exposure to air from a busy street, with a PNC of around
10,000 particles/cm3, was found on MVF in young healthy adults
(Brauner et al., 2008b). A few hours of controlled exposure to wood
smoke was not associated with effects on MVF in young healthy atopic
individuals (Forchhammer et al., 2012),whereas lowMVFwas associat-
ed with high levels of ambient PM2.5 on the preceding two days (Pope
et al., 2011). The indoor PNC levels in our study partly originated from
the use of candles (Bekö et al., 2013), whichmight a have limited effect
on vascular function. Moreover, MVF and other measures of endothelialfunction might be most susceptible to ambient PM from trafﬁc-related
sources due to a combination of small size and chemical composition.
We found a positive association between levels of HbA1c and indoor
PNC, but not with outdoor PNC and PMmass, which could be consistent
with long-term effects related to indoor exposure. The level of HbA1c
is an indicator of the average level of blood glucose over the previous
2–3 months and related to the risk of diabetes and cardiovascular dis-
ease in the general population (Jorgensen et al., 2004). A recent study
investigating the relationship between long-term air pollution exposure
and risk factors for cardiovascular diseases found that the HbA1c level
was positively associated with the levels of PM, O3 and NO2 (Chuang
et al., 2011). Similarly, the risk of diabetes was associated with long-
term exposure to trafﬁc-related air pollution in Denmark (Andersen
et al., 2012). Such adverse effects of air pollution could be related to
chronic low-grade systemic inﬂammation.
We found that indoor levels of PNC and endotoxin in settled dust
were inversely associated with lung function with a 2% decrease per
IQR change for both these pollutants. This dual association between
PNC and endotoxin and lower lung function could be related to the abil-
ity of indoor PM as allergen carrier (Ormstad, 2000). The composition of
indoor UFP may play an important role in their adverse health effects,
since around 20% of airborne particles are biological components, and
some of them e.g. endotoxin may contribute to PM toxicity (Degobbi
et al., 2011). However, the bioaerosol levels in Danish homes can vary
considerably, depending on occupancy and season (Frankel et al.,
2012; Madsen et al., 2012). The association between indoor exposure
to allergens and lower lung function is well known for individuals
with respect to respiratory allergies or asthma (Sublett, 2011). Although
our subjects did not suffer from asthma, the association between lung
function and exposure to endotoxin in the home is consistent with
results of previous studies on the prevalence of asthma in adults and
children (Michel et al., 1996; Rabinovitch et al., 2005).
There are only few investigations on the association between expo-
sure to indoor-levels of PM and lung function, although it has been hy-
pothesized to be an important determinant for respiratory symptoms
and diseases including asthma (Delﬁno, 2002; Weisel, 2002). Most
studies included subjectswith existing disease and none included expo-
sure in terms of PNC. A 2-week panel study, of asthmatic children found
inverse associations between FEV1 and exposure to PM2.5, personally
monitored exposure showing the strongest associations followed by in-
door PM exposure, and then outdoor and central-site measurements
(Delﬁno et al., 2004). A 3-year panel study on children with asthma
and adults with or without chronic obstructive pulmonary disease
found inverse associations between lung function and exposure to
PM2.5 in both adults and children with lung disease and most consis-
tentlywith respect to indoor exposures (Trenga et al., 2006). Most stud-
ies of healthy individuals have reported no associations between indoor
PM2.5 and lung function (Ebelt et al., 2005; Jansen et al., 2005; Yeatts
et al., 2012). Two studies including both smokers and subjects who
were exposed to environmental tobacco smoke, but otherwise healthy,
have shown associations between lung function or symptoms with
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ing winter (Simoni et al., 2003) and in an indoor air ﬁltration crossover
study with young adults (Weichenthal et al., 2013). By contrast, our
investigation encompassed only non-smokers without asthma, living
in non-smoking homes and lung function was not associated with
PM2.5 only with PNC levels.
Possibly speciﬁc effects of high outdoor PNC levels from trafﬁc have
been found in adults with asthma, showing decreased lung function
after short-term exposure in trafﬁc-dense environments (McCreanor
et al., 2007). An exposure contrast in PNC (9000–66,500 particles/cm3)
for 5 h while exercising intermittently at ﬁve different locations
including two trafﬁc sites, an urban background location, an underground
train station and a farm in theNetherlandswas associatedwithdecreased
lung function in younghealthy subjects (Strak et al., 2012). However, in
healthy young adults no effect on lung function was observed during
24 h of exposure to air from a busy street in Copenhagen, Denmark,
with PNC of 6000–15,000 particles/cm3 (Brauner et al., 2009). Simi-
larly, a 2-hour exposure to high PNC in a road tunnel (1.3 × 105 par-
ticles/mL) or concentrated ambient UFP (2.1 × 105 particles/cm3)
were not associated with altered lung function in young and healthy
subjects (Larsson et al., 2007; Samet et al., 2009).
Many studies on the associations between air pollution-mediated
systemic inﬂammation and cardiovascular diseases have assessed CRP
and leukocyte counts as markers of inﬂammation (Delﬁno et al.,
2005). We found a signiﬁcant positive association between indoor ex-
posure to PM2.5 and elevated levels of CRP.We also found positive asso-
ciations between outdoor particle levels and CRP, but they were not
statistically signiﬁcant. A 7-day intervention study with air ﬁltration in
the homes of a wood smoke impacted area found an association
between the indoor concentration of PM2.5 and CRP (Allen et al.,
2011), whereas three other studies with air ﬁltration in Copenhagen,
Denmark, showed no effect on CRP (Brauner et al., 2008a,b; Karottki
et al., 2013). There seem to bemixed results with regard to associations
between ambient or individual-level PM2.5 exposure and CRP; some
studies have shown positive associations (Huttunen et al., 2012; Zhao
et al., 2013), whereas other studies have reported no effect on CRP levels
in the circulation (Liu et al., 2009; Ruckerl et al., 2007a; Strak et al., 2013;
Wu et al., 2012). A review concluded that there was an association be-
tween air pollution exposure and elevated levels of CRP in children,
whereas there were inconsistent results on healthy adults (Li et al.,
2012). Other studies have reported positive associations between expo-
sure to ambient PNC and CRP in healthy individuals (Hertel et al., 2010)
and in coronary heart disease patients (Delﬁno et al., 2008, 2009;
Panasevich et al., 2009; Ruckerl et al., 2006).
We found that the levels of leukocytes, lymphocytes, monocytes,
and eosinophils were associated with indoor PNC, but not with outdoor
levels of air pollution. One study in Indian children showed that indoor
exposure to biomass fuels was associated with increased leukocyte,
neutrophil, and eosinophil counts (Padhy and Padhi, 2009). No consis-
tent association between exposure to ambient PM and lymphocytes,
monocytes, basophils and eosinophils were reported in a recent study
on in-trafﬁc exposure in healthy adults (Zuurbier et al., 2011). Other
studies have reported no effects on leukocytes or neutrophils after ex-
posures to concentrated ambient air (Gong et al., 2003), diesel exhaust
(Lucking et al., 2008; Mills et al., 2005, 2007), or to concentrated ambi-
entUFP (Gong et al., 2008). By contrast, short-term increases in ambient
air PM levels have been associated with increased levels of circulating
leukocytes in the general population and patients with chronic pulmo-
nary diseases (Bruske et al., 2010; Schwartz, 2001). Two studies report-
ed a decrease in circulating leukocytes after exposure to ambient air PM
(Ruckerl et al., 2007b) or concentrated ambient air particles (Ghio et al.,
2003), while a recent study reported a signiﬁcant increase in neutro-
phils after long-term exposure to PM10, PM2.5, O3 and NO2 (Chuang
et al., 2011).
The expression of adhesion markers CD11b and CD62L on mono-
cytes was signiﬁcantly inversely associated with indoor PNC, endotoxinor fungi levels in our study, suggesting that systemic inﬂammation re-
sponses were affected by the exposure. Indoor exposure to endotoxin
may decrease the expression of CD62L onmonocytes because of activa-
tion of the cells and rapid cleavage of L-selectin from the surface of leu-
kocytes upon activation (Hafezi-Moghadam and Ley, 1999). Continuous
exposure to indoor endotoxin might also result in an adaptation mech-
anism, suggesting an important role of L-selectin in downregulation of
inﬂammatory response to dust-contaminated environments (Israel-
Assayag and Cormier, 2002). The decreased expression of CD11b could
be caused by the attachment of monocytes with this adhesion marker
to the endothelium. Our results on CD11b expression are consistent
with the results from a 2-hour inhalation exposure of healthy subjects
to ultraﬁne carbon particles, where the subjects had lower expression
of adhesion molecules CD11b/CD18 on monocytes and CD11b/CD18
and CD49d on granulocytes (Frampton et al., 2006). By contrast, chronic
biomass smoke exposure was associated with increased surface expres-
sion of CD11b/CD18 in circulating granulocytes and monocytes in
women (Ray et al., 2006).
A detailed assessment of the indoor source activities in the homes of
the subjects in the present study showed that candle burning, cooking
and toasting resulted in increased PNC andwere responsible on average
for 51% of the residential integrated exposure (Bekö et al., 2013). Candle
burning occurred in half of the homeswhere, on average, it was respon-
sible for almost 60% of the integrated exposure (Bekö et al., 2013). Yet,
the exposure assessed as total average PNC was very closely correlated
with exposure assessed speciﬁcally in relation to candle burning, which
also showed the same signiﬁcant associations with lower lung function
and with higher HbA1c and leukocyte counts. Cooking contributed
much less to event-related exposure and was not associated with any
health outcome. This was the case, possibly because cooking events
were of relatively short duration and they occurred in kitchens with
fume hoods and at a certain distance from themonitor placed in the liv-
ing room. Accordingly, exposure to emissions from candles and possibly
similar indoor sources might contribute to decreased lung function and
inﬂammatory activation of leukocytes. Candle burning also emits nitro-
gen dioxide, which could contribute to the association related to lower
lung function. The lack of association between lung function andwheth-
er or not candles are used in the homes of the participants in general
suggests that if the association with the candle burning source events
is causal, it would be a short-term effect of high level exposure.Moreover,
individuals with asthma could well be more susceptible, in line with dec-
rements in lung function related to trafﬁc related PNC (McCreanor et al.,
2007; Strak et al., 2012).
A limitation of our exposure assessment is that we did not analyze
the composition of indoor and outdoor PM, which might have helped
explaining the different associations with the health outcomes we ob-
served in our study population. However, indoor and outdoor PNC
were inversely correlated, whereas the indoor particle mean diameter
was correlated with outdoor particle mean diameter and PM mass.
This might have suggested that only larger particles from ambient air
contributed to indoor levels, but this was not reﬂected in correlations
between indoor and outdoor PM2.5. Furthermore, in our analyses of
source events (peaks in PNC) and the corresponding exposure, some
of the peaks may have been attributable to more than one source,
while other peaks could not be attributed to a known source (unknown
events). Some of these unknown eventsmay have been due to addition-
al candle burning. Another limitation is that we used outdoor exposure
data collected at a central monitoring site and we did not monitor per-
sonal exposure, which couldmore accurately reﬂect the exposure of the
subjects. This is a particular problem for outdoor PNC, which show high
spatial variation (Ruckerl et al., 2011). In addition, we did not have spe-
ciﬁc information on the time spent outdoors, although adjustment for
time when the home was unoccupied as the best available estimate of
this did not change the signiﬁcant associations. Furthermore, we ap-
plied an exploratory approach and tested a large number of associations
between a series of outcomes and a number of exposures. Thus, some of
380 D.G. Karottki et al. / Environment International 73 (2014) 372–381the statistically signiﬁcant associations might be due to chance. More-
over, our cross-sectional approach is sensitive to confounding from indi-
vidual factors, whichwould be less of a problem in a panel study design.
Although adjustment for all available variables had no inﬂuence on the
associations, residual confounding by other factors, such as diet, may
have occurred. Finally, the cross-sectional design cannot discriminate
between the potential long- and short-term effects of indoor air pollut-
ants if the levels are representative of the daily exposure of the subjects
in their home environment.
5. Conclusion
The study suggests that the exposure to PNC in the outdoor environ-
ment may have an adverse effect on MVF, while the exposure to PNC
and bioaerosols in the indoor environment may have adverse effects
on lung function and some markers of systemic inﬂammation and
diabetes.
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